Achieve Life Sciences (ACHV) Depreciation and Depletion (2011 - 2017)
Achieve Life Sciences (ACHV) recorded quarterly Depreciation and Depletion of $37000.0 in Q2 2017, down 60.22% on a QoQ basis from $93000.0 in Q1 2017, and down 21.28% year-over-year from $47000.0 in Q2 2016.
Achieve Life Sciences (ACHV) Depreciation and Depletion (2011 - 2017) Analysis & Trends
Achieve Life Sciences has disclosed Depreciation and Depletion across 7 years of filings, most recently posting $37000.0 for Q2 2017.
- Quarterly Depreciation and Depletion fell 21.28% year-over-year to $37000.0 in Q2 2017, while the trailing twelve-month figure through Jun 2017 was $215000.0 (down 6.93% YoY) and the FY2021 annual result came in at $27000.0, down 15.62% from the prior year.
- Depreciation and Depletion declined to $37000.0 in Q2 2017, from $93000.0 in the prior quarter.
- Over five years, Depreciation and Depletion peaked at $93000.0 in Q1 2017 and troughed at $37000.0 in Q2 2017.
- A 5-year average of $56222.2 and a median of $55500.0 in 2013 frame the typical range for Depreciation and Depletion.
- Annual changes were most pronounced in 2013 — Depreciation and Depletion soared 133.33% — and 2016, when it sank 39.39%.
- Tracing ACHV's Depreciation and Depletion over 5 years: stood at $65000.0 in 2013, then decreased by 10.77% to $58000.0 in 2014, then increased by 13.79% to $66000.0 in 2015, then plunged by 39.39% to $40000.0 in 2016, then retreated by 7.5% to $37000.0 in 2017.
- Business Quant data shows ACHV's Depreciation and Depletion at $37000.0 in Q2 2017, $93000.0 in Q1 2017, and $40000.0 in Q4 2016.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Depreciation and Depletion (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 762,369.55 Bn | 762,369.51 Bn | - | 1,395.22 |
| 2 | Belite Bio | 55,096.00 Bn | 55,096.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,755.80 Bn | 17,755.79 Bn | - | - |
| 4 | Legend Biotech | 3,486.00 Bn | 3,485.71 Bn | 242.10 Mn | - |
| 5 | Akari Therapeutics | 1,737.42 Bn | 1,737.41 Bn | - | - |
| 6 | Evaxion A | 1,551.28 Bn | 1,551.26 Bn | - | - |
| 7 | Psyence Biomedical | 227.32 Bn | 227.31 Bn | - | -1,330.00 |
| 8 | Vertex Pharmaceuticals | 110.84 Bn | 103.59 Bn | 2.59 Bn | - |
| 9 | Abivax | 91.71 Bn | 91.71 Bn | - | - |
| 10 | Achieve Life Sciences | 93.71 Mn | 63.22 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2017 | 37,000.00 |
| Jun 30, 2017 | 37,000.00 |
| Mar 31, 2017 | 93,000.00 |
| Mar 31, 2017 | 93,000.00 |
| Dec 31, 2016 | 40,000.00 |
| Dec 31, 2016 | 40,000.00 |
| Sep 30, 2016 | 45,000.00 |
| Sep 30, 2016 | 45,000.00 |
| Jun 30, 2016 | 47,000.00 |
| Jun 30, 2016 | 47,000.00 |
| Mar 31, 2016 | 56,000.00 |
| Mar 31, 2016 | 56,000.00 |
| Dec 31, 2015 | 66,000.00 |
| Dec 31, 2015 | 66,000.00 |
| Sep 30, 2015 | 62,000.00 |
| Sep 30, 2015 | 62,000.00 |
| Jun 30, 2015 | 70,000.00 |
| Jun 30, 2015 | 70,000.00 |
| Mar 31, 2015 | 46,000.00 |
| Mar 31, 2015 | 46,000.00 |